Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Chlorambucil Workflows for Cancer Drug Response
2026-08-11
Build more informative Chlorambucil experiments by separating growth inhibition from actual cell killing. This workflow covers solvent handling, time-resolved viability and apoptosis measurements, model-specific interpretation, and troubleshooting for leukemia, glioma, and comparative cell studies.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-09
The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) supports HRP-based immunoblotting when low-abundance protein bands are difficult to visualize. It is intended for research use with nitrocellulose or PVDF membranes and should not be used for diagnostic, clinical, or medical applications.
-
MG-262: Mapping Proteostasis in Inflamed Lung Cells
2026-08-08
MG-262, or Z-Leu-Leu-Leu-B(OH)2, enables reversible interrogation of proteasome function at the intersection of inflammation, ubiquitin signaling, and epithelial cell fate. This article translates cytokine and glucocorticoid findings into a mechanistically controlled proteasome inhibition assay strategy.
-
(5Z)-7-Oxozeaenol in Stress-Signaling Assays
2026-08-07
Explore how the TAK1 inhibitor (5Z)-7-Oxozeaenol can clarify the AMPK–SQSTM1 stress-response circuit. This article translates recent mechanistic findings into assay-design decisions while distinguishing metabolic-stress evidence from inflammation applications.
-
Palomid 529 (P529): A Next-Generation PI3K/Akt/mTOR Inhibito
2026-08-07
Explore how Palomid 529 (P529), a potent dual mTORC1/2 inhibitor, is reshaping cancer research through advanced pathway targeting and radiotherapy enhancement. Uniquely, we analyze the translational impact and protocol strategies beyond what existing resources provide.
-
Vincristine Sulfate: Optimized Protocols for Cancer Research
2026-08-06
Vincristine sulfate, a microtubule disrupter from APExBIO, empowers cancer research with proven anti-proliferative effects and versatile protocol adaptability. This guide details stepwise workflows, troubleshooting strategies, and novel assay insights for maximizing reproducibility and translational value in oncology labs.
-
Technical Guide to Cathepsin B Inhibitor CA-074 (SKU A1926)
2026-08-06
Cathepsin B inhibitor CA-074 (SKU A1926) is a potent, selective tool for dissecting the role of cathepsin B in processes like cancer metastasis, neurodegeneration, and immune modulation. It is recommended where rigorous, mechanistically grounded inhibition of cathepsin B is required, but should not be used as a pan-cathepsin or broad-spectrum cysteine protease inhibitor due to its high selectivity.
-
Golgi-Tracker Green: Advancing Live-Cell Golgi Apparatus Lab
2026-08-05
Golgi-Tracker Green leverages BODIPY FL-labeled C5-ceramide to deliver precise, photostable labeling of the Golgi in live cells—outperforming legacy probes. Discover how its specificity empowers robust workflows in lipid transport and sphingolipid metabolism analysis, with actionable troubleshooting and protocol guidance for dynamic cellular imaging.
-
Sunitinib: Multi-Targeted RTK Inhibitor in Renal Cell Carcin
2026-08-05
Sunitinib, a potent multi-targeted receptor tyrosine kinase inhibitor, enables advanced interrogation of tumor angiogenesis, proliferation, and apoptosis in cancer models. Recent breakthroughs in combination strategies, like chrysin-induced ferroptosis, offer new solutions for overcoming resistance and optimizing experimental outcomes in renal cell carcinoma research.
-
Haloprogin: Broad-Spectrum Antifungal Agent for Dermatophyte
2026-08-04
Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) is a potent topical antimicrobial with demonstrated efficacy against dermatophytes, yeasts, and Gram-positive bacteria. Its low MIC values and robust in vivo performance establish it as a benchmark for dermatophytosis and Candida research. This article synthesizes key evidence, protocol parameters, and practical integration for laboratory and translational workflows.
-
IDO1 Inhibition Unmasks Tumor-Protective STAT3 Activation
2026-08-04
This study reveals that pharmacological inhibition of IDO1, while intended to enhance anti-tumor immunity, paradoxically activates the tumor-intrinsic JAK2/STAT3 pathway via IL-6, resulting in tumor-protective effects. The findings underscore the need for combined therapeutic strategies that target both IDO1 and JAK2/STAT3 signaling to overcome resistance in cancer immunotherapy.
-
Tin Mesoporphyrin IX: Optimizing Heme Oxygenase Activity Ass
2026-08-03
Tin Mesoporphyrin IX (chloride) empowers researchers to achieve highly reproducible, nanomolar-precision inhibition of heme oxygenase in metabolic and virology workflows. This guide details stepwise protocols, troubleshooting strategies, and real-world cross-domain insights for maximizing experimental rigor with APExBIO’s trusted inhibitor.
-
Vascular Effects of JAK Inhibitors on Endothelial Cells in I
2026-08-03
This study systematically compares the vascular impact of multiple JAK inhibitors, including tofacitinib citrate, on human endothelial cells exposed to inflammatory cytokines. Key findings reveal nuanced anti-inflammatory effects but also highlight molecule-specific limitations in countering procoagulant and cytotoxic responses, informing careful assay design in immune regulation research.
-
Vincristine Sulfate: Deep Mechanistic Insights for Oncology
2026-08-02
Explore the advanced mechanisms and unique solubility strategies of vincristine sulfate in cancer research. This in-depth guide reveals practical assay considerations, referencing recent literature, and distinguishes itself from conventional summaries.
-
RapaLink-1: Unraveling mTORC1 Dormancy and Resistance in Can
2026-08-01
Explore how RapaLink-1, a third-generation mTOR inhibitor, enables precise control of cell dormancy and overcomes resistance in cancer research. This in-depth analysis highlights unique assay design insights and the translational significance of mTORC1 inhibition.